47 related articles for article (PubMed ID: 1188744)
1. Proceedings: Fibrinogen biosynthesis.
Blombäck B; Redman C; Kudryk B
Thromb Diath Haemorrh; 1975 Sep; 34(1):327. PubMed ID: 1188744
[No Abstract] [Full Text] [Related]
2. Biosynthesis of canine fibrinogen: in vitro synthesis of A alpha, B beta and gamma precursor chains.
Yu S; Redman CM; Goldstein J; Blombäck B
Biochem Biophys Res Commun; 1980 Oct; 96(3):1032-8. PubMed ID: 7437057
[No Abstract] [Full Text] [Related]
3. Biosynthesis of dog fibrinogen. Characterization of nascent fibrinogen in the rough endoplasmic reticulum.
Kudryk B; Okada M; Redman CM; Blombäck B
Eur J Biochem; 1982 Jul; 125(3):673-82. PubMed ID: 7117261
[No Abstract] [Full Text] [Related]
4. [Biological properties of fibrinogen degradation products by thrombin].
Buczko W
Pol Tyg Lek; 1981 Jun; 36(23):855-6. PubMed ID: 7024948
[No Abstract] [Full Text] [Related]
5. Proceedings: Differences in crosslinking reactivity of fibrin molecules formed during differential release of fibrinopeptides A and B.
Furlan M; Seelich T; Beck EA
Thromb Diath Haemorrh; 1975 Nov; 34(2):550. PubMed ID: 1198418
[No Abstract] [Full Text] [Related]
6. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
[TBL] [Abstract][Full Text] [Related]
7. Studies on the functionality of newly synthesized fibrinogen after treatment of acute myocardial infarction with streptokinase, increase in the rate of fibrinopeptide release.
Reganon E; Vila V; Aznar J; Lacueva V; Martinez V; Ruano M
Thromb Haemost; 1993 Dec; 70(6):978-83. PubMed ID: 8165621
[TBL] [Abstract][Full Text] [Related]
8. Proceedings: Immunological cross reaction between chains of human fibrinogen.
Gårdlund B
Thromb Diath Haemorrh; 1975 Sep; 34(1):328. PubMed ID: 52899
[No Abstract] [Full Text] [Related]
9. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
Rooney MM; Mullin JL; Lord ST
Biochemistry; 1998 Sep; 37(39):13704-9. PubMed ID: 9753458
[TBL] [Abstract][Full Text] [Related]
10. In vitro studies of secretion of platelet factor 4 and generation of fibrinopeptid A in native whole blood.
Lorenz R; Gebhart S; Heptner W; Classen M
Thromb Res; 1988 Apr; 50(1):231-6. PubMed ID: 3400083
[No Abstract] [Full Text] [Related]
11. Nonrandom catabolism of proteins in the formation of antigenic peptide fragments.
Thomas DW; Schauster JL; Hoffman MD; Wilner GD
J Immunol; 1985 Aug; 135(2):1259-63. PubMed ID: 3874235
[TBL] [Abstract][Full Text] [Related]
12. [The levels of fibrinopeptide A and fibrinopeptide B beta in the urine from patients with chronic glomerulonephritis during urokinase therapy].
Miura M; Tomino Y; Inoue W; Tamura S; Nomoto Y; Sakai H; Itoh K
Rinsho Byori; 1985 Jun; 33(6):652-6. PubMed ID: 4032804
[No Abstract] [Full Text] [Related]
13. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
Weisel JW; Veklich Y; Gorkun O
J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
[TBL] [Abstract][Full Text] [Related]
14. [Thrombin-fibrinogen interaction: release of fibrinopeptides and the effects of ATP].
Gurrieri MA
Medicina (Firenze); 1990; 10(1):51-2. PubMed ID: 2381284
[TBL] [Abstract][Full Text] [Related]
15. The utility of plasma fibrinopeptide assays.
Owen J
Thromb Haemost; 1989 Sep; 62(2):807-10. PubMed ID: 2814929
[No Abstract] [Full Text] [Related]
16. The action of thrombin on modified fibrinogen.
Osbahr AJ
Thromb Haemost; 1983 Jun; 49(3):208-13. PubMed ID: 6410533
[TBL] [Abstract][Full Text] [Related]
17. The effect of products of degradation of fibrinogen A and B on the arterial blood pressure in the rat.
Barczak-Osińska J; Buczko W; Wiśniewski K
Pol J Pharmacol Pharm; 1983; 35(4):279-83. PubMed ID: 6664935
[TBL] [Abstract][Full Text] [Related]
18. Analysis of human fibrinopeptides by high-performance liquid chromatography.
Kehl M; Lottspeich F; Henschen A
Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1661-4. PubMed ID: 7319478
[TBL] [Abstract][Full Text] [Related]
19. Genetically abnormal fibrinogens--strategies for structure elucidation, including fibrinopeptide analysis.
Henschen A; Kehl M; Southan C
Curr Probl Clin Biochem; 1984; 14():273-320. PubMed ID: 6391842
[No Abstract] [Full Text] [Related]
20. Fibrinogen storage disease without hypofibrinogenemia associated with estrogen therapy.
Simsek Z; Ekinci O; Cindoruk M; Karakan T; Degertekin B; Akyol G; Unal S
BMC Gastroenterol; 2005 Nov; 5():36. PubMed ID: 16287505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
